Richard F Ambinder, M.D

Internal Medicine, Medical Oncology

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

BALTIMORE, MD

QC-verified· April 2026 PI on 1 trialNPI: 1528022407

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Post-transplant lymphoproliferative disease

Clinical trials (1)

NCT00278200

Verify independently

ClinicalTrials.gov PI search for Richard F Ambinder
NPPES NPI registry entry

Other specialists for Post-transplant lymphoproliferative disease

Peers ranked by clinical-trial PI role, publications, and verification quality.

Birte Wistinghausen, M.D
Children's Oncology Group
NY
Cyrille TOUZEAU, Prof
CHU Nantes France
Aurore PERROT, Prof
IUCT Toulouse France
Kurt Gunter, MD, M.D
Inozyme Pharma, Inc.
MA
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Corey Cutler, MD, MPH, F.N.P
Dana-Farber Cancer Institute
UT
Chanaz LOUNI
The Institute for Functional Medicine
Leona Holmberg
Fred Hutch/University of Washington Cancer Consortium
WA

See all specialists for Post-transplant lymphoproliferative disease →

← Back to specialists directory